Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer.
Joanne Nyaboe Nyarangi-DixMagdalena GoertzGeorgi GradinarovLuisa HoferViktoria SchützClaudia GaschJan Philipp RadtkeMarkus HohenfellnerPublished in: BMC urology (2019)
RsRARP in high-risk PCa is feasible and results in excellent continence rates, even after postoperative radiotherapy. The potency rates are promising but need further clarification in larger cohorts. Reliable oncologic outcomes require longterm follow-up and are awaited.
Keyphrases
- robot assisted
- radical prostatectomy
- prostate cancer
- locally advanced
- rectal cancer
- minimally invasive
- neoadjuvant chemotherapy
- squamous cell carcinoma
- radiation therapy
- phase ii study
- patients undergoing
- early stage
- radiation induced
- clinical trial
- metabolic syndrome
- insulin resistance
- study protocol
- glycemic control